Policy & Medicine - Legal, Regulatory, and Compliance Issues

A recent report from Cegedim looked at how pharmaceutical promotion influences physician prescribing behavior.  The study looked…

As we noted earlier this month, the Food and Drug Administration (FDA) published a Notice for Comment regarding the Examination of…

Next week the Patient Centered Outcomes Research Institute (PCORI) will be meeting to plan out how to conduct comparative…

One of the largest—and also most controversial—pieces of the Affordable Care Act (ACA or health care reform) is the Independent…

Biopharmaceutical research companies produce the highest-value jobs, the types of jobs Americans want in the 21st century economy,…

Over the past several years, academic medical centers, professional medical organizations,industry trade groups, and federal…

Last week, Massachusetts General Hospital and Harvard Medical School sanctioned renowned child psychiatrist Dr. Joseph Biederman…

During the American Medical Association Annual Meeting, the AMA House of Delegates noted that, “the time and money physicians…

Late last month, I recieved several  "breaking news" alerts the U.S. Senate Finance Committee had begun an investigation regarding…

The Accreditation Council for Continuing Medical Education (ACCME) discussed a number of issues in this past month’s newsletter.…